Galactorrhea and Parkinson-like syndrome: an adverse effect of alpha-methyldopa.
D000293:Adolescent; D000568:Amenorrhea / Q000150:complications; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D016030:Kidney Transplantation; D007775:Lactation Disorders / Q000139:chemically induced*; D008750:Methyldopa / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010530:Peritoneal Dialysis; D011247:Pregnancy; D011507:Proteinuria / Q000209:etiology; D014202:Tremor / Q000139:chemically induced*
D006830:Hydralazine; D008750:Methyldopa